Contemporary Outcomes of Pulmonary Valve Endocarditis: A 16-Year Single Centre Experience
| Autor: | Steven M. Gordon, James C. Witten, Bo Xu, Nabin K. Shrestha, Brian P. Griffin, Gösta B. Pettersson, Nicolas Isaza, Maria Vega Brizneda, Shinya Unai |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Pulmonary and Respiratory Medicine medicine.medical_specialty Prosthesis-Related Infections Population Heart Valve Diseases 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Interquartile range Internal medicine medicine Humans Endocarditis 030212 general & internal medicine Risk factor education Retrospective Studies Heart Valve Prosthesis Implantation Pulmonary Valve education.field_of_study business.industry Medical record Retrospective cohort study Middle Aged medicine.disease medicine.anatomical_structure Echocardiography Infective endocarditis Pulmonary valve Female Cardiology and Cardiovascular Medicine business Follow-Up Studies Forecasting |
| Zdroj: | Heart, Lung and Circulation. 29:1799-1807 |
| ISSN: | 1443-9506 |
| Popis: | BACKGROUND Limited data exist regarding the clinical characteristics and contemporary outcomes of patients with pulmonary valve (PoV) infective endocarditis (IE). METHODS This is a retrospective cohort study of patients with a confirmed diagnosis of IE affecting the PoV at our centre between January 2002 and October 2018. Electronic medical records were reviewed to gather the clinical and echocardiographic variables. The population was subdivided according to risk factor profiles: group 1: miscellaneous risk factors; group 2: patients with congenital heart disease (CHD); and group 3: patients who inject drugs (PWID). The primary outcome was all-cause mortality. RESULTS Out of 2,124 cases of IE during the study period, 24 (1.1%) patients had PoV IE. The majority of cases of PoV IE occurred in patients with prosthetic valves (54.2%). Coagulase-negative Staphylococci species were the most common micro-organisms. Seventy-five per cent (75%) of the patients required surgical management. The median follow-up was 2.8 years (interquartile range: 0.2-5.3 years). Patients with miscellaneous risk factors were older (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect